Wearable tech may soon spot heart problems without a doctor visit
NCT ID NCT04843371
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a simple, non-invasive sensor called photoplethysmography (PPG) — already found in many smartwatches — can accurately predict how well the heart pumps blood (ejection fraction) and other heart health measures. Researchers will have 500 adults wear a PPG device during an echocardiogram and use artificial intelligence to see if the sensor's signals can replace or supplement the ultrasound test. If it works, it could make heart monitoring easier and more accessible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Photoplethysmography (PPG) sensor
- What this could lead to
- If successful, this could allow people to monitor key heart metrics like ejection fraction and blood pressure using a simple wearable device, without needing an echocardiogram.
- What could go wrong
- This is an early-stage observational study with 500 participants, so the results may not apply to everyone. The PPG predictions are based on AI models that may not be accurate enough for clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
East Jefferson General Hospital
RECRUITINGNew Orleans, Louisiana, 70006, United States
-
Tulane Doctors - Speciality Care - Napoleon
RECRUITINGNew Orleans, Louisiana, 70115, United States
-
University Medical Center
RECRUITINGNew Orleans, Louisiana, 70112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- Can a daily pill keep a rare heart disease in check for the long haul?
- Heart scans may unlock hidden risks in minority communities
- Prepping the body before heart surgery: could exercise shorten hospital stays?
- New flowchart could reduce ICU time and pacemakers after TAVR
- Gene hunt launched for kids with heart muscle disease